DEVICE CATEGORY · MER
Stent, Urethral, Prostatic, Permanent Or Semi-Permanent
FDA classification: Unknown. Device class 3.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
ProVee System for BPHP250011/S005 | Proverum, Ltd. | PMA supplement | Nov 3, 2026 | FDA |
ProVee System for BPHP250011/S006 | Proverum, Ltd. | PMA supplement | Sep 24, 2026 | FDA |
ProVee System for BPHP250011/S004 | Proverum, Ltd. | PMA supplement | Jul 1, 2026 | FDA |
ProVee System for BPHP250011/S003 | Proverum, Ltd. | PMA supplement | Jun 15, 2026 | FDA |
ProVee System for BPHP250011/S002 | Proverum, Ltd. | PMA supplement | Jun 3, 2026 | FDA |
ProVee System for BPHP250011/S001 | Proverum, Ltd. | PMA supplement | Mar 19, 2026 | FDA |
| Zenflow, Inc. | PMA approval | Dec 11, 2025 | FDA | |
ProVee System for BPHP250011 | Proverum, Ltd. | PMA approval | Dec 9, 2025 | FDA |
Source information
Follow the FDA links to view the original records.





